Triple Marker

🔍 Overview

The Triple Marker test is a prenatal blood screening test performed during the second trimester of pregnancy (usually between 15–20 weeks). It helps assess the risk of certain chromosomal abnormalities and neural tube defects in the unborn baby.

📋 Test Summary

This test helps to assess the risk of:

• Down syndrome (Trisomy 21)

• Edwards syndrome (Trisomy 18)

• Neural tube defects

Markers tested include:

• Alpha-fetoprotein (AFP)

• Human Chorionic Gonadotropin (hCG)

• Unconjugated Estriol (uE3)

✔ Non-invasive screening test
✔ Used along with ultrasound findings
✔ Helps guide further diagnostic testing

⏱ Reports Within: 24–48 Hours
🧪 Sample: Blood
👩 Age: Pregnant Women (Second Trimester)
🚻 Gender: Female
🍽 Fasting: Not Required